SCHEMBL4593992

SCHEMBL4593992

Nc1ccc2c(n1)CNCCC2

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PNMT P11086 4/20 0.41
HTR2C P28335 3/20 0.38
HTR2A P28223 2/20 0.38
ADRA2A P08913 4/20 0.37
ADRA2B P18089 4/20 0.37
ADRA2C P18825 4/20 0.37
DRD2 P14416 2/20 0.33
DRD3 P35462 2/20 0.33
CD44 P16070 2/20 0.33
HTR6 P50406 1/20 0.31
HTR2B P41595 1/20 0.31
MAOB P27338 1/20 0.31
DRD1 P21728 1/20 0.30
DRD4 P21917 1/20 0.30
DRD5 P21918 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23104752 0.89 HTR2C (0.45) PNMTHTR2CADRA2AADRA2BADRA2C
SCHEMBL29222757 0.82 PNMT (0.49) PNMTHTR2CHTR2AADRA2AADRA2B
SCHEMBL23561744 0.79 PNMT (0.41) PNMTHTR2CHTR2AADRA2AADRA2B
SCHEMBL23114392 0.79 PNMT (0.41) PNMTHTR2CHTR2AADRA2AADRA2B
SCHEMBL12696301 0.78 CYP3A4 (0.44) PNMTHTR2CADRA2AADRA2BADRA2C
SCHEMBL31587209 0.77 ADRA2A (0.47) HTR2CHTR2AADRA2AADRA2BADRA2C
SCHEMBL29522031 0.77 ADRA2A (0.52) HTR2CHTR2AADRA2AADRA2BADRA2C
SCHEMBL3373891 0.77 ADRA2A (0.52) HTR2CHTR2AADRA2AADRA2BADRA2C
SCHEMBL3162510 0.77 ADRA2A (0.47) HTR2CHTR2AADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL29591748 0.76 CYP3A4 (0.43) PNMTHTR2CADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-A1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT Boehringer Ingelheim International GmbH (DE) 2008-03-19 EP disclosed
WO-2007003536-A1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-11 WO disclosed